FR2265355A1 - - Google Patents

Info

Publication number
FR2265355A1
FR2265355A1 FR7410913A FR7410913A FR2265355A1 FR 2265355 A1 FR2265355 A1 FR 2265355A1 FR 7410913 A FR7410913 A FR 7410913A FR 7410913 A FR7410913 A FR 7410913A FR 2265355 A1 FR2265355 A1 FR 2265355A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7410913A
Other versions
FR2265355B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BLUM JEAN FR
Original Assignee
BLUM JEAN FR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BLUM JEAN FR filed Critical BLUM JEAN FR
Priority to FR7410913A priority Critical patent/FR2265355B1/fr
Priority to CA222,416A priority patent/CA1058168A/fr
Priority to GB11481/75A priority patent/GB1506934A/en
Priority to CH389475A priority patent/CH609680A5/fr
Priority to JP50037366A priority patent/JPS5939425B2/ja
Priority to DE19752513842 priority patent/DE2513842A1/de
Priority to BE154829A priority patent/BE827255A/fr
Priority to US05/567,752 priority patent/US4072703A/en
Publication of FR2265355A1 publication Critical patent/FR2265355A1/fr
Application granted granted Critical
Publication of FR2265355B1 publication Critical patent/FR2265355B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
FR7410913A 1974-03-28 1974-03-28 Expired FR2265355B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR7410913A FR2265355B1 (fr) 1974-03-28 1974-03-28
CA222,416A CA1058168A (fr) 1974-03-28 1975-03-18 Derives de la 3-aminodeshydrothiophene-2-one
GB11481/75A GB1506934A (en) 1974-03-28 1975-03-19 Derivatives of 3-amino-dihydrothiophen-2-one
JP50037366A JPS5939425B2 (ja) 1974-03-28 1975-03-26 Ｎ，ｓ−ジアシルホモシステイン誘導体の製法
CH389475A CH609680A5 (en) 1974-03-28 1975-03-26 Process for the N-acylation of homocysteine
DE19752513842 DE2513842A1 (de) 1974-03-28 1975-03-27 3-amino-dihydrothiophenon-2-derivate und ihr herstellungsverfahren
BE154829A BE827255A (fr) 1974-03-28 1975-03-27 Nouveaux derives de l'amino-3 dihydrothiophenone-2
US05/567,752 US4072703A (en) 1974-03-28 1975-04-14 Thiol esters of homocysteine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7410913A FR2265355B1 (fr) 1974-03-28 1974-03-28

Publications (2)

Publication Number Publication Date
FR2265355A1 true FR2265355A1 (fr) 1975-10-24
FR2265355B1 FR2265355B1 (fr) 1977-11-04

Family

ID=9136994

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7410913A Expired FR2265355B1 (fr) 1974-03-28 1974-03-28

Country Status (7)

Country Link
US (1) US4072703A (fr)
JP (1) JPS5939425B2 (fr)
BE (1) BE827255A (fr)
CA (1) CA1058168A (fr)
DE (1) DE2513842A1 (fr)
FR (1) FR2265355B1 (fr)
GB (1) GB1506934A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
EP0120359A1 (fr) * 1983-03-23 1984-10-03 YASON S.r.l Dérivés de tétrahydrothiophénone actifs sur les affections du système respiratoire
EP0149904A1 (fr) * 1984-01-06 1985-07-31 Becton Dickinson and Company Produits obtenus à partir d'agents d'accouplement
WO1991010421A1 (fr) * 1990-01-16 1991-07-25 Reckitt & Colman Utilisation de derives n-acyle d'homocysteine pour modifier la structure de la keratine et des compositions cosmetiques contenant ces derives
EP0618312A1 (fr) * 1993-03-02 1994-10-05 Prodesfarma, S.A. Procédé d'obtention de N-acetyl homocystéine thiolactone à partir d'homocystine DL par des méthodes électrochimiques

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105789A (en) * 1976-05-10 1978-08-08 E. R. Squibb & Sons, Inc. Carboxyalkylacylamino acids
US4269849A (en) * 1979-02-22 1981-05-26 Chevron Research Company Fungicidal 3-(N-cycloalkylcarbonyl-N-arylamino)-gamma-butyrolactones and gamma-butyrothiolactones
IT1134458B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1215238B (it) * 1985-02-22 1990-01-31 Chiesi Farma Spa Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
JP3434824B2 (ja) * 1993-07-02 2003-08-11 ザ・ユニバーシティ・オブ・ノッティンガム 例えばｎ−（３−オキシヘキサノイル）ホモセリンラクトンのような免疫抑制剤及び抗アレルギー性化合物
US5616775A (en) * 1994-05-05 1997-04-01 Bristol-Myers Squibb Co. Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
US8624063B2 (en) 2009-06-30 2014-01-07 Wisconsin Alumni Research Foundation Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
WO2013037984A1 (fr) * 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Conjugués anti-inflammatoires et antioxydants permettant de traiter les troubles métaboliques
ES2953522T3 (es) * 2014-04-08 2023-11-14 Abliva Ab Compuestos de succinato novedosos con permeabilidad celular
US10526278B2 (en) 2017-10-19 2020-01-07 Wisconsin Alumni Research Foundation Inhibitors of quorum sensing receptor LasR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2935529A (en) * 1956-12-21 1960-05-03 Degussa Process for the production of homocysteine compounds
DE1199276B (de) * 1962-09-20 1965-08-26 Degussa Verfahren zur Herstellung von D, L-Homo-cysteinderivaten
FR2068398B2 (fr) * 1969-10-07 1973-01-12 Rech Pharmac Scientif
FR2129877B1 (fr) * 1971-03-18 1974-08-02 Fuveau Sa
DE2328391A1 (de) * 1972-06-19 1974-01-10 Degussa Trialkoxycinnamoylaminocarbonsaeuren

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
EP0061386A1 (fr) * 1981-03-19 1982-09-29 REFARMED, Recherches Pharmaceutiques et Medicales S.A. Acides ((2-oxo-3-tétrahydrothiénylcarbamoyl)-alkylthio) acétiques, leurs sels et leurs esters, leur procédé de préparation et les compositions pharmaceutiques en contenant
EP0120359A1 (fr) * 1983-03-23 1984-10-03 YASON S.r.l Dérivés de tétrahydrothiophénone actifs sur les affections du système respiratoire
EP0149904A1 (fr) * 1984-01-06 1985-07-31 Becton Dickinson and Company Produits obtenus à partir d'agents d'accouplement
WO1991010421A1 (fr) * 1990-01-16 1991-07-25 Reckitt & Colman Utilisation de derives n-acyle d'homocysteine pour modifier la structure de la keratine et des compositions cosmetiques contenant ces derives
EP0618312A1 (fr) * 1993-03-02 1994-10-05 Prodesfarma, S.A. Procédé d'obtention de N-acetyl homocystéine thiolactone à partir d'homocystine DL par des méthodes électrochimiques

Also Published As

Publication number Publication date
DE2513842A1 (de) 1975-10-09
US4072703A (en) 1978-02-07
GB1506934A (en) 1978-04-12
BE827255A (fr) 1975-09-29
FR2265355B1 (fr) 1977-11-04
JPS50135025A (fr) 1975-10-25
CA1058168A (fr) 1979-07-10
JPS5939425B2 (ja) 1984-09-22

Similar Documents

Publication Publication Date Title
FR2281275B1 (fr)
FR2266946A1 (fr)
FR2265355B1 (fr)
FR2289560B1 (fr)
IN143169B (fr)
JPS50141636A (fr)
JPS50104693A (fr)
JPS50150613A (fr)
AR199089A1 (fr)
AU495844B2 (fr)
FR2287507B1 (fr)
JPS5031137Y1 (fr)
AU7474374A (fr)
JPS50105326A (fr)
CH582789A5 (fr)
AU479987A (fr)
CH583017A5 (fr)
BG20670A1 (fr)
CH582457A5 (fr)
AU480170A (fr)
BG19607A1 (fr)
CH581272A5 (fr)
CH580740A5 (fr)
CH581010A5 (fr)
CH583746A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse